LAGUNA HILLS, Calif., May 1 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced that as of May 2, it will have officially changed its name, obtained a new trading symbol, effected a 3000 for 1 reverse stock split, and launched its new website at http://www.lifesteminternational.com.
The new web site gives significant background on the Company's proprietary Stem Cell MicroBank(TM), its unique method of stem cell banking that allows healthy individuals to collect and store their stem cells for possible future therapeutic use. The web site also explains the Company's Research Reagents Division, which includes K-D Medical, Inc. and MoleculA, Inc. in Columbia, Maryland. Also included on the site is information for the investor on our financial filings and news releases, as well as information on management and the scientific advisory board.
LifeStem's Stem Cell MicroBank(TM) Service is a process that involves the harvesting of adult stem cells in micro quantities from both blood and adipose tissue. The cells are then cryopreserved for future possible therapeutic applications and therapies, such as grafting new skin cells for burn victims, regenerating corneas and producing and regulating insulin for diabetics.
About LifeStem International, Inc.
LifeStem International, Inc. (OTC Bulletin Board: LSTM) is the emerging life sciences company (http://www.lifesteminternational.com), concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.
Note: Certain statements in this news release may contain
"forward-looking" information within the meaning of rule 175 under the
Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and
are subject to the safe harbor created by those rules. We use words such as
"anticipate," "believe," "expect," "future," "intend," "plan," and similar
expressions to identify forward-looking statements. These statements
including those related to being in a large and growing market, exhibiting
rapid growth characteristics, and having a growth strategy, are
forward-looking statements. These forward-looking statements are only
predictions and are subject to certain risks, uncertainties and
assumptions. Some of the risks, uncertainties and assumptions that could
cause actual results to differ materially from estimates or assumptions in
this press release include the risk that we will not be able to grow our
revenues and market share, the risk that our prices do not remain
competitive and the risk that we will not achieve profitability. Additional
risks are identified and described in the Company's public filings with the
Securities and Exchange Commission, including our most recent Report on
Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made
herein are as of the date of this press release and should not be relied
upon as of any subsequent date. The Company's past performance is not
necessarily indicative of its future performance. The Company does not
undertake, and the Company specifically disclaims, any obligation to update
any forward-looking statements to reflect occurrences, developments,
events, or circumstances after the date of such statement.
Contact: Paul Knopick
E & E Communications
|SOURCE LifeStem International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved